Last reviewed · How we verify
NCT06827951
Potential Benefits of Parent Child Interaction Therapy (PCIT)
trial testing Parent-Child Interaction Therapy (PCIT) in Autonomic Dysregulation in 80 participants. Currently enrolling.
1 June 2026
Quick facts
| Lead sponsor | University of Florida |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 14 February 2025 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 June 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Parent-Child Interaction Therapy (PCIT)
Conditions studied
- Autonomic Dysregulation — all drugs for Autonomic Dysregulation →
- Anxiety — all drugs for Anxiety →
- Depression — all drugs for Depression →
- Parent-Child Relations — all drugs for Parent-Child Relations →
Sponsor
University of Florida
Who can join
Adults 18 to 89, any sex, with Autonomic Dysregulation or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to explore possible benefits of Parent-Child Interaction Therapy (PCIT). The main goals of the study are: * To investigate whether pre-survey measures of autonomic reactivity relate to the overall functioning of participants. * To examine the effects of PCIT To identify individual characteristics that influence the effects of PCIT. Participants will: * complete 5 online surveys (1x pre-PCIT, 3x during PCIT, and 1x post-PCIT) * complete the PCIT program
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06827951
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Parent-Child Interaction Therapy (PCIT)
Trials testing the same drug.
- NCT06311474 — Remote Assessment and Intervention for Behavior Problems in Kids With TSC · NA · completed
- NCT04061031 — Improving Self-Regulation Among Adopted Children · NA · withdrawn
- NCT03260725 — Evaluating the Feasibility of Internet-delivered PCIT · NA · completed
Other University of Florida trials
Trials by the same sponsor.
- NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
- NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
- NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
- NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
- NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06827951 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Florida
- Last refreshed: 12 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06827951.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing